​

Funding Round

Series A - PierianDx

Series A - PierianDx

Investment Firm

Overview

PierianDx is catalyzing global adoption of genomic sequencing in healthcare

Announced Date

Jan 07, 2016

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Health Catalyst

Health Catalyst

No designation

Health Catalyst Capital

Health Catalyst Capital

Health Catalyst Capital is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorARUP Laboratories
Participant InvestorInova Translational Medicine Institute
Participant InvestorHealth Catalyst Capital
Participant InvestorHealth Catalyst

Round Details and Background

PierianDx raised $9250000 on 2016-01-07 in Series A

PierianDx is catalyzing global adoption of genomic sequencing in healthcare

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2014
Seed Round - PierianDx
1-1.5M
Nov 02, 2021
Venture Round - PierianDx
6-30.0M
Nov 02, 2021
Debt Financing - PierianDx
-undefined
Jan 07, 2016
Series A - PierianDx
4-9.3M

Recent Activity

There is no recent news or activity for this profile.